激动κ阿片受体在改善高脂血症引起的血管内皮功能失调中的作用机制探讨
《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]
- 期数:
- 2013年第4期
- 页码:
- 486-489
- 栏目:
- 综述
- 出版日期:
- 2013-07-25
文章信息/Info
- Title:
- Improvement effect of κ-opioid receptor on hyperlipidemia-induced endothelial dysfunction
- Author(s):
- ZHENG Xu-yang1; YANG Zhi-wei1; ZHAO Shi-hao1; CHU Xiao-yue2; FENG Na2; LI Juan2; JIA Min2; PEI Jian-ming2
- (1.Team 3, School of Stomatology, 2.Department of Physiology, Fourth Military Medical University, Xi’an 710032, Shaanxi, China)
- Keywords:
- hyperlipidemia; endothelial dysfunction; κ-opioid receptor
- 分类号:
- R971.2；R589.2
- DOI:
- -
- 文献标识码:
- A
- 摘要:
- 高脂血症引起的血管内皮功能失调是引起代谢综合征及多种心血管疾病并发症的关键环节之一。高脂血症造成血管内皮损伤的机制包括导致血管内皮分泌的血管舒、缩因子平衡失调、促进炎症反应和促进血管内皮氧化应激等。同时，激动κ阿片受体（κ-opioid receptor，κ-OR）在多种心血管疾病研究中被证实可以起到明确的心血管保护作用，但关于激动κ-OR在高脂血症引起的血管内皮功能失调中的作用仍有待研究。本文综述了高脂血症导致的血管内皮损伤和激动κ-OR所起的血管内皮保护作用的研究进展，探讨了激动κ-OR在改善高脂血症引起的血管内皮功能失调中的作用，为进一步研究激动κ-OR所起的作用提供了思路。
- Abstract:
- Endothelial dysfunction induced by hyperlipidemia is recognized as one of the pivotal factors in the pathogenesis of metabolic syndrome and a variety of cardiovascular complications. Mechanisms involved in hyperlipidemia-induced endothelial dysfunction include the imbalance between the secretion of vasoconstrictor and vasodilator, vasculitis and up-regulated oxidative stress in endothelial cells. Many studies have proved that the activation of κ-opioid receptor (κ-OR) has some cardiovascular protective effect. However, the role of κ-OR in hyperlipidemia-induced endothelial dysfunction is still unclear. This paper reviews the current knowledge about hyperlipidemia-induced endothelial dysfunction and the cardiovascular protective effect of κ-OR activation on hyperlipidemia-induced endothelial dysfunction.
参考文献/References
[1]吴晓东,王 微,周 贺,等.κ-阿片受体和缝隙连接蛋白Cx43与心律失常的关系[J].心脏杂志,2011,23(5):667-669.
[2]Li W,Wang D,Song G,et al.The effect of combination therapy of allicin and fenofibrate on high fat diet-induced vascular endothelium dysfunction and liver damage in rats[J].Lipids Health Dis,2010,9(9): 131-137.
[3]Zimman A,Podrez EA.Regulation of platelet function by class B scavenger receptors in hyperlipidemia[J].Arterioscler Thromb Vasc Biol,2010,30(12):2350-2356.
[4]Skoro-Sajer N,Hack N,Sadushi-Kolici R,et al.Pulmonary vascular reactivity and prognosis in patients with chronic thromboembolic pulmonary hypertension:a pilot study[J].Circulation,2009,119(2):298-305.
[5]Chen Z,Bakhshi FR,Shajahan AN,et al.Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promotes eNOS/caveolin-1 binding and eNOS inhibition[J].Mol Biol Cell,2012,23(7):1388-1398.
[6]Chen J,Zhao H,Yang Y,et al.Lipid-lowering and antioxidant activities of Jiang-Zhi-Ning in Traditional Chinese Medicine[J].J Ethnopharmacol,2011,134(3):919-930.
[7]李 榕,王文清,张海锋,等.高血脂通过氧化/硝基化双重作用介导大鼠血管内皮功能失调［J］. 中国病理生理杂志, 2010, 26(8):1494-1497.
[8]Guo HT,Zhang RH,Huang LY,et al.Sensitized hypotensive effect of U50,488H in SHR and its mechanisms involved[J].Arch Med Res,2007,38(7):723-729.
[9]Li J,Zhang P,Zhang QY,et al.Effects of U50,488H on hypoxia pulmonary hypertension and its underlying mechanism[J].Vascul Pharmacol,2009,51(2-3):72-77.
[10]Tong G,Sun ZC,Wei XF,et al.U50,488H postconditioning reduces apoptosis after myocardial ischemia and reperfusion[J].Life Sci,2010,88(1-2):31-38.
[11]吴晓东,王 微,周 贺,等.阿片受体激动剂U50,488H对血管紧张素II诱导内皮细胞产生白介素-6和白介素-8的影响[J].中国药理学通报,2010,26(7):922-925.
[12]Wu XD,Zhang B,Fan R,et al.U50,488H inhibits neutrophil accumulation and TNF-α induction induced by ischemia-reperfusion in rat heart[J].Cytokine,2011,56(2):503-507.
[13]Li J,Wu F,Zhang HF,et al.Insulin inhibits leukocyte-endothelium adherence via an Akt-NO-dependent mechanism in myocardial ischemia/reperfusion[J].J Mol Cell Cardiol,2009,47(4):512-519.
备注/Memo
- 备注/Memo:
- 收稿日期：2012-09-19.基金项目：国家自然科学基金项目资助 （81270402,30971060,31100827,30900535,31200875）；陕西省自然科学基金项目资助（ 2010K01195，2011JM4001） 通讯作者：裴建明，教授，主要从事κ阿片受体介导心脏保护研究 Email:jmpei8@fmmu.edu.cn 作者简介：郑煦暘，本科生 Email：zhengxuyang123456@126.com 共同第一作者：杨智伟，本科生 Email：502278415@qq.co
常用功能
统计/Statistics
- 摘要浏览/Viewed822
- 评论/Comments
